Genomic-based surveillance of carbapenem-resistant and/or colistin-resistant Enterobacteriaceae at the EU level
The primary public health objective of this type of EU-wide WGS-based surveillance is:
— to determine the occurrence, geographic distribution and the population dynamics of high-risk carbapenem-resistant and/or colistin resistant Enterobacteriaceae clones and/or transmissible resistance/genetic elements of critical public health importance in Europe in order to inform risk assessment, prevention and control policies.
The secondary objectives are:
— to identify the epidemiological risk factors for infection or colonisation with carbapenem-resistant and/or colistin-resistant Enterobacteriaceae at bacterial, clonal and sub-genomic level,
— to support the Member States in developing technical capability and proficiency for genomic-based surveillance and risk assessment of multidrug-resistant bacteria with epidemic potential.
Sista ansökningsdag
Tidsfristen för mottagande av anbud var 2017-08-17.
Upphandlingen offentliggjordes den 2017-06-27.
Leverantörer
Följande leverantörer nämns i tilldelningsbeslut eller andra upphandlingsdokument:
Vem?
Vad?
Var?
Upphandlingshistorik
| Datum |
Dokument |
| 2017-06-27
|
Meddelande om upphandling
|
| 2018-01-22
|
Meddelande om tilldelning
|